People · Operator

Amir H. Nashat, Ph.D.

Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology

1
Companies
1
Filings
$286.2M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Dewpoint Therapeutics, Inc.BiotechnologySeries D+$286.2M$438.0M2025
Operator network

Amir H. Nashat, Ph.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Amir H. Nashat · 3 companies · 1 sharedAmir H. NashatAmeet A. Nathwani, M.D. · 1 companies · 1 sharedAmeet A. Nathwani…Ameet Nathwani, M.D. · 1 companies · 1 sharedAmeet Nathwani, M…Anthony A. Hyman, Ph.D. · 1 companies · 1 sharedAnthony A. Hyman,…Bruce H. Beutel · 1 companies · 1 sharedBruce H. BeutelElisabeth A. Leiderman · 1 companies · 1 sharedElisabeth A. Leid…Fabio H. Pucci, Ph.D. · 1 companies · 1 sharedFabio H. Pucci, P…Giuseeppe H. Ciaramella, Ph.D. · 1 companies · 1 sharedGiuseeppe H. Ciar…Giuseppe H. Ciaramella, Ph.D. · 1 companies · 1 sharedGiuseppe H. Ciara…Guiseppe A. Ciaramella, Ph,D. · 1 companies · 1 sharedGuiseppe A. Ciara…Isaac A. Klein, M.D., Ph.D. · 1 companies · 1 sharedIsaac A. Klein, M…Joel D. Sendek · 1 companies · 1 sharedJoel D. SendekJuergen A. Eckhardt, M.D. · 1 companies · 1 sharedJuergen A. Eckhar…Jurgen A. Eckhardt, M.D. · 1 companies · 1 sharedJurgen A. Eckhard…Lori A. Escobedo · 1 companies · 1 sharedLori A. EscobedoMark A. Murcko, Ph.D. · 1 companies · 1 sharedMark A. Murcko, P…Oliver H. Brandicourt, M.D. · 1 companies · 1 sharedOliver H. Brandic…Olivier Brandicourt, M.D. · 1 companies · 1 sharedOlivier Brandicou…Olivier H. Brandicourt, M.D. · 1 companies · 1 sharedOlivier H. Brandi…Regina A. Barzilay, Ph.D. · 1 companies · 1 sharedRegina A. Barzila…Regina Barzilay, Ph.D. · 1 companies · 1 sharedRegina Barzilay, …Richard A. Young, Ph.D. · 1 companies · 1 sharedRichard A. Young,…Dewpoint Therapeutics, Inc. · $286.2M raisedDewpoint Therapeutics…Amir H. Nashat, Ph.D.AP
Amir H. Nashat, Ph.D. Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Amir H. Nashat, Ph.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Amir H. Nashat13
Regina Barzilay, Ph.D.11
Guiseppe A. Ciaramella, Ph,D.11
Mark A. Murcko, Ph.D.11
Olivier Brandicourt, M.D.11
Richard A. Young, Ph.D.11
Elisabeth A. Leiderman11
Ameet Nathwani, M.D.11
Isaac A. Klein, M.D., Ph.D.11
Srinivas Akkaraju, M.D., Ph.D.11
Lori A. Escobedo11
Fabio H. Pucci, Ph.D.11
Anthony A. Hyman, Ph.D.11
Giuseppe H. Ciaramella, Ph.D.11
Joel D. Sendek11
Srinivas H. Akkaraju, M.D., Ph.D.11
Ameet A. Nathwani, M.D.11
Olivier H. Brandicourt, M.D.11
Juergen A. Eckhardt, M.D.11
Regina A. Barzilay, Ph.D.11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.